- Industry Solutions
Industry Solutions
From reshaping the quote to cash process, to transforming engagement with channels partners, to achieving excellence in global product launch, Model N enables digital reinvention with industry-specific solutions that maximize revenue.
- Right block
Contact Sales
Ebook
whitepaper
whitepaper
How to avoid the risk associated with 340B duplicate discounts
Rapid growth of the 340B program, as well as lack of transparency and oversight of this program and the Medicaid Drug Rebate Program, have created major challenges. One in particular – duplicate discounts – poses a significant risk for pharmaceutical manufacturers.
Duplicate discounts explained
This eBook provides an overview of the issue and its impact on the industry and outlines data-driven strategies manufacturers can implement to identify and prevent duplicate discounts.
Key takeaways
- Learn what duplicate discounts are and how they occur, including the most common scenarios that lead to double dipping
- Understand the challenges manufacturers face in tracking the massive number of 340B transactions
- Get expert advice for spotting and avoiding duplicate discounts to protect revenue
2025 State of Revenue Report
The 7th annual State of Revenue Report reveals the power of data and analytics in optimizing life sciences and high-tech revenue. VIEW whitepaper
